Increasing precision in the measurement of change in pediatric neurodegenerative disease.

Eisengart, J B; Daniel, M H; Adams, H R; Williams, P; Kuca, B; Shapiro, E

Eisengart, J B; Daniel, M H; Adams, H R; Williams, P; Kuca, B; Shapiro, E.

Afiliação

Eisengart JB; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. Electronic address: eisen139@umn.edu.
Daniel MH; Mark Daniel Services LLC, MN, USA.
Adams HR; Department of Neurology, University of Rochester, Rochester, NY, USA.
Williams P; Pearson, Minneapolis, MN, USA.
Kuca B; Allievex Corporation, Marblehead, MA, USA.
Shapiro E; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA; Partner, Shapiro Neuropsychology Consulting, LLC, Portland, OR, USA.

Mol Genet Metab ; 137(1-2): 201-209, 2022.

Article em En | MEDLINE | ID: mdl-36115283

Assuntos

Doenças Neurodegenerativas; Criança; Lactente; Humanos; Doenças Neurodegenerativas/diagnóstico; Testes de Inteligência; Cognição

Palavras-chave

Ability score; Clinical outcomes; Clinical trials; Growth scale value; Measurement, neurocognitive decline

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google